Although the overall predictive ability of AF apoA-II for poor outcomes was only moderate, AF concentrations exceeding 45 μg/ml predicted death or the necessity for liver transplantation within 90 days, with a sensitivity of 78% and a specificity of 59% (Fig. 3C). The gene discussed is APOA2; the disease is atrial fibrillation.